B. Riley Predicts Vaxart’s Q1 Earnings (NASDAQ:VXRT)
Vaxart, Inc. (NASDAQ:VXRT – Free Report) – Research analysts at B. Riley raised their Q1 2025 earnings per share (EPS) estimates for shares of Vaxart in a note issued to investors on Wednesday, March 26th. B. Riley analyst M. Mamtani now expects that the biotechnology company will earn ($0.07) per share for the quarter, up […]
